Inhibition of Aβ1–42 peptide aggregation using short ss-oligonucleotide as polyions: an in silico approach

Journal of Biomolecular Structure and Dynamics

Volumn 35, Issue 7, 2017, Pages 1401-1406

  Dutta, Mary ^a   Mattaparthi, Venkata Satish Kumar ^a  

^a TEZPUR UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; NUCLEIC ACID; OLIGONUCLEOTIDE; SS OLIGONUCLEOTIDE; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN; ION; PEPTIDE FRAGMENT; PROTEIN AGGREGATE;

ALGORITHM; AMINO ACID SEQUENCE; COMPUTER MODEL; ENCAPSULATION; LETTER; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN AGGREGATION INHIBITION; PROTEIN METABOLISM; RISK FACTOR; STATIC ELECTRICITY; ALZHEIMER DISEASE; ANTAGONISTS AND INHIBITORS; CHEMISTRY; COMPUTER SIMULATION; GENETICS; HUMAN;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; COMPUTER SIMULATION; HUMANS; IONS; OLIGONUCLEOTIDES; PEPTIDE FRAGMENTS; PROTEIN AGGREGATES;

EID: 84980021950     PISSN: 07391102     EISSN: 15380254     Source Type: Journal    
DOI: 10.1080/07391102.2016.1189358     Document Type: Letter

References (15)

1. Abraham, J. N., Kedracki, D., Prado, E., Gourmel, C., Maroni, P., & Nardin, C., (2014). Effect of the interaction of the amyloid β (1–42) peptide with short single-stranded synthetic nucleotide sequences:Morphological characterization of the inhibition of fibrils formation and fibrils disassembly. Biomacromolecules, 15, 3253–3258. doi:10.1021/bm501004q
2. Barrantes, A., Camero, S., Garcia-Lucas, A., Navarro, P. J., Benitez, M. J., & Jimenez, J. S., (2012). Alzheimer's disease amyloid peptides interact with DNA, as proved by surface plasmon resonance. Current Alzheimer Research, 9, 924–934. doi:10.2174/156720512803251101
3. Berhanu, W. M., & Masunov, A. E., (2015). Atomistic mechanism of polyphenol amyloid aggregation inhibitors:Molecular dynamics study of Curcumin, Exifone, and Myricetin interaction with the segment of tau peptide oligomer. Journal of Biomolecular Structure and Dynamics, 33, 1399–1411. doi:10.1080/07391102.2014.951689
4. Bhattacharjya, S., & Balaram, P., (1997). Teflon-coated peptides. Biopolymers, 42, 125–128. doi:10.1002/(SICI)1097-0282(199708)42:2<125:AID-BIP1>3.0
5. Doig, A. J., & Derreumaux, P., (2015). Inhibition of protein aggregation and amyloid formation by small molecules. Current Opinion in Structural Biology, 30, 50–56. doi:10.1016/j.sbi.2014.12.004
6. Ghosh, S., Pandey, N. K., Banerjee, P., Chaudhury, K., Nagy, N. V., & Dasgupta, S., (2015). Copper (II) directs formation of toxic amorphous aggregates resulting in inhibition of hen egg white lysozyme fibrillation under alkaline salt-mediated conditions. Journal of Biomolecular Structure and Dynamics, 33, 991–1007. doi:10.1080/07391102.2014.921864
7. Jucker, M., (2012). The amyloid state of proteins in human diseases. Cell, 148, 1188–1203. doi:10.1016/j.cell.2012.02.022
8. Kroth, H., Ansaloni, A., Varisco, Y., Jan, A., Sreenivasachary, N., Rezaei-Ghaleh, N., & Pihlgren, M., (2012). Discovery and structure activity relationship of small molecule inhibitors of toxic β-amyloid-42 fibril formation. Journal of Biological Chemistry, 287, 34786–34800. doi:10.1074/jbc.M112.357665
9. Kumar, A., Srivastava, S., Tripathi, S., Singh, S. K., Srikrishna, S., & Sharma, A., (2015). Molecular insight into amyloid oligomer destabilizing mechanism of flavonoid derivative 2-(4′ benzyloxyphenyl)-3-hydroxy-chromen-4-one through docking and molecular dynamics simulations. Journal of Biomolecular Structure and Dynamics, 34(6), 1–12, doi:10.1080/07391102.2015.1074943
10. Li, J., Hoop, C. L., Kodali, R., Sivanandam, V. N., & van der Wel, P. C., (2011). Amyloid-like fibrils from a domain-swapping protein feature a parallel, in-register conformation without native-like interactions. Journal of Biological Chemistry, 286, 28988–28995. doi:10.1074/jbc.M111.261750
11. Lyubchenko, Y. L., (2015). Amyloid misfolding, aggregation, and the early onset of protein deposition diseases:Insights from AFM experiments and computational analyses. AIMS Molecular Science, 2, 190–210. doi:10.3934/molsci.2015.3.190
12. Macedo, B., Millen, T. A., Braga, C. A., Gomes, M. P., Ferreira, P. S., Kraineva, J., & Cordeiro, Y., (2012). Nonspecific prion protein–nucleic acid interactions lead to different aggregates and cytotoxic species. Biochemistry, 51, 5402–5413. doi:10.1021/bi300440e
13. Mitternacht, S., Staneva, I., Härd, T., & Irbäck, A., (2010). Comparing the folding free-energy landscapes of Aβ42 variants with different aggregation properties. Proteins:Structure, Function, and Bioinformatics, 78, 2600–2608. doi:10.1002/prot.22775
14. Park, S., Yoon, J., Jang, S., Lee, K., & Shin, S., (2015). The role of the acidic domain of α-synuclein in amyloid fibril formation:a molecular dynamics study. Journal of Biomolecular Structure and Dynamics, 34(2), 1–8, doi:10.1080/07391102.2015.1033016
15. Udomprasert, A., Bongiovanni, M. N., Sha, R., Sherman, W. B., Wang, T., Arora, P. S., & Seeman, N. C., (2014). Amyloid fibrils nucleated and organized by DNA origami constructions. Nature Nanotechnology, 9, 537–541. doi:10.1038/nnano.2014.102